Phibro Animal Health Corporation logo

Phibro Animal Health Corporation (PB8)

Market Open
8 Dec, 07:01
33. 20
-1.4
-4.05%
738.85M Market Cap
35.95 P/E Ratio
0.48% Div Yield
0 Volume
1.1 Eps
34.6
Previous Close
Day Range
33.2 33.2
Year Range
14.2 39.2
Want to track PB8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 57 days

Summary

PB8 trading today lower at €33.2, a decrease of 4.05% from yesterday's close, completing a monthly decrease of -6.74% or €2.4. Over the past 12 months, PB8 stock gained 66.83%.
PB8 pays dividends to its shareholders, with the most recent payment made on Sep 24, 2025. The next announced payment will be in In 1 weeks on Dec 17, 2025 for a total of €0.12.
The last earnings report, released on Nov 05, 2025, exceeded the consensus estimates by 0.13%. On average, the company has surpassed earnings expectations by 0.06%, based on the last three reports. The next scheduled earnings report is due on Feb 03, 2026.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

PB8 Chart

Similar

S8A
Spar Group Limited
5.35
0%
M1A
Momentum Group Limited
1.85
-1.07%
Auto Italia Holdings Ltd.
-
-
B3X
SinterCast AB
9.7
-0.82%
RZK
Skellerup Holdings Limited
2.66
+2.31%
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term

Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 week ago
PAHC or BSX: Which Is the Better Value Stock Right Now?

PAHC or BSX: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 2 weeks ago
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term

Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 weeks ago

Phibro Animal Health Corporation (PB8) FAQ

What is the stock price today?

The current price is €33.20.

On which exchange is it traded?

Phibro Animal Health Corporation is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is PB8.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.48%.

What is its market cap?

As of today, the market cap is 738.85M.

When is the next earnings date?

The next earnings report will release on Feb 03, 2026.

Has Phibro Animal Health Corporation ever had a stock split?

No, there has never been a stock split.

Phibro Animal Health Corporation Profile

Specialty Retail Industry
Consumer Discretionary Sector
Jack Clifford Bendheim CEO
XBER Exchange
US71742Q1067 ISIN
US Country
1,940 Employees
26 Nov 2025 Last Dividend
- Last Split
11 Apr 2014 IPO Date

Overview

Phibro Animal Health Corporation serves as a multi-national entity dedicated to the health and nutritional needs of animals across the globe, including in the United States, Israel, Brazil, Ireland, among others. With a foundation laid in 1946 and rebranded from Philipp Brothers Chemicals, Inc. to its current name in July 2003, Phibro has established its headquarters in Teaneck, New Jersey. The company is structured around three primary segments: Animal Health, Mineral Nutrition, and Performance Products, catering to a wide range of animal species such as poultry, swine, beef and dairy cattle, aquaculture, and companion animals like dogs. Phibro's operations encompass the development, manufacture, and marketing of an extensive portfolio directed towards enhancing animal health, performance, and welfare, ensuring food safety, and sustaining environmental and agricultural ecosystems.

Products and Services

Animal Health Products:

Antibacterials, anticoccidials, nutritional specialties, vaccines, and vaccine adjuvants – This suite of products is designed to combat bacterial infections, prevent diseases like coccidiosis, and improve the overall health and performance of animals across various sectors. Phibro places a strong emphasis on enhancing food safety and animal welfare through its innovative health solutions.

Microbial and Bioproducts:

Developing, manufacturing, and marketing for animal health and nutrition, industrial, environmental, and agricultural applications – Phibro leverages biotechnology to offer products aimed at improving animal health and nutrition. These solutions also extend to industrial, environmental, and agricultural sectors, showcasing the company's versatile application of microbial and bio-technologies.

Vaccine Products:

Conventionally licensed and autogenous vaccines, along with adjuvants for animal vaccine manufacturers – Phibro plays a pioneering role in the development and manufacture of both standard and custom vaccines tailored to the specific needs of animals. This includes the provision of adjuvants that enhance the effectiveness of these vaccines.

Mineral Nutrition:

Trace minerals and nutritional supplements for livestock diets – With an acute focus on mineral nutrition, Phibro develops and markets formulations rich in essential trace minerals like zinc, manganese, copper, and iron. These products are vital for fortifying animal feeds, ensuring livestock receive balanced dietary nutrition to maintain optimal health and productivity.

Specialty Ingredients:

For personal care, industrial chemical, and chemical catalyst industries – Beyond its core offerings in animal health and nutrition, Phibro extends its expertise to the provision of specialty ingredients catered to the personal care, industrial chemical, and chemical catalyst sectors. This diversification underscores Phibro’s commitment to leveraging its chemical manufacturing prowess across a broad spectrum of industries.

Phibro strategically distributes its agricultural and animal health solutions through its extensive network of local sales offices, targeting integrated poultry, swine, and cattle integrators, as well as commercial animal feed manufacturers, wholesalers, and distributors globally.

Contact Information

Address: Glenpointe Centre East
Phone: 201 329 7300